超过5%股东持股披露「修订」
ORIC Pharmaceuticals(ORIC)02-08 06:15
$ORIC制药(ORIC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006812 Act: 34 Size: 12 KB 网页链接
简介:ORIC Pharmaceuticals, Inc.于2014年8月在特拉华州成立。该公司是临床阶段的生物制药公司,致力于通过克服癌症抵抗力来改善患者的生活。
今开:9.7 | 昨收:9.71 |
最高:9.79 | 最低:9.15 |
涨停价: | 跌停价: |
总市值:631747017 |
ORIC Pharmaceuticals(ORIC)02-08 06:15
$ORIC制药(ORIC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006812 Act: 34 Size: 12 KB 网页链接
ORIC Pharmaceuticals(ORIC)02-07 05:15
$ORIC制药(ORIC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000038 Act: 34 Size: 81 KB 网页链接
ORIC Pharmaceuticals(ORIC)02-07 05:15
$ORIC制药(ORIC)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000089 Act: 33 Size: 4 KB 网页链接
ORIC Pharmaceuticals(ORIC)04-25 04:15
$ORIC Pharmaceuticals(ORIC)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-110069 Act: 34 Size: 509 KB 网页链接
ORIC Pharmaceuticals(ORIC)03-09 05:25
$ORIC制药(ORIC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-007345 Size: 5 KB 网页链接
ORIC Pharmaceuticals(ORIC)03-12 05:35
$ORIC制药(ORIC)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-24-064987 Act: 33 Size: 868 KB 网页链接
ORIC Pharmaceuticals(ORIC)02-15 07:25
$ORIC制药(ORIC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000217 Act: 34 Size: 48 KB 网页链接
ORIC Pharmaceuticals(ORIC)04-25 04:25
$ORIC Pharmaceuticals(ORIC)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-110119 Act: 34 Size: 3 MB 网页链接
ORIC Pharmaceuticals(ORIC)02-09 09:05
$ORIC制药(ORIC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-003114 Size: 7 KB 网页链接
ORIC Pharmaceuticals(ORIC)02-14 07:45
$ORIC制药(ORIC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000150 Act: 34 Size: 42 KB 网页链接
牛唐2023-08-07 23:36
$ORIC制药(ORIC)$ 又一个60%+的收益。$阿里巴巴(BABA)$ $理想汽车(LI)$查看全文
chuminhua2022-03-23 17:14
3月22日,ORIC Pharmaceuticals $ORIC制药(ORIC)$ 正在放弃用于支持其 2020 年 IPO 的主要项目,此前该癌症药物在几项早期试验中均未达到重点。
ORIC 周一收盘后的第四季度更新中宣布了管线变化。随着周二市场开盘,这一消息使股价下跌 32% 至约 4.50 美元。
ORIC-101是一种糖皮质激素受体...查看全文
牛唐2021-10-14 23:36
$ORIC制药(ORIC)$ 四季度更新CD73的研发情况。股价很强势。$Corvus制药(CRVS)$ $阿斯利康(AZN)$查看全文
牛唐2021-09-22 15:32
CD73概念股:
1、CD73抗体药物 $Corvus制药(CRVS)$ $阿斯利康(AZN)、$诺华制药(NVS)、$百时美施贵宝(BMY)、$因塞特(INCY)、$Innate Pharma(IPHA)$
2、CD73 小分子药物 $Arcus Biosciences(RCUS)、$ORIC制药(ORIC);
$恒瑞医药(SH600276)$查看全文
Spica2021-09-18 06:13
回复@Spica: 终于播的种子收获啦,@牛唐 CD73概念股,网页链接 $天境生物(IMAB)$ $ORIC制药(ORIC)$//@Spica:$Corvus制药(CRVS)$ 老板继续开启买买买模式,CD73还有新故事吗?$ORIC制药(ORIC)$ $天境生物...查看全文
Spica2021-08-24 13:00
$Corvus制药(CRVS)$ 老板继续开启买买买模式,CD73还有新故事吗?$ORIC制药(ORIC)$ $天境生物(IMAB)$查看全文
Spica2021-06-30 09:46
高管频频加仓$Corvus制药(CRVS)$ ,同样CD73靶点的难兄难弟$ORIC制药(ORIC)$ 也在底部趴着呢查看全文
产业链观察2021-06-28 21:04
药闻| 2021 年 6 月 28 日,专注于开发解决治疗耐药机制的治疗方法的临床阶段的肿瘤公司$ORIC制药(ORIC)$ 今天宣布美国食品和药物管理局 (FDA) 已批准该公司的 ORIC-533 研究新药申请 (IND) 进行首次人体临床试验。
ORIC-533 是一种高效的、口服生物可利用的 CD73 小分子抑制剂,CD73 是腺苷途...查看全文
Spica2021-04-15 08:06
最近加仓了 $天境生物科技(IMAB)$ ASCO公布CD73抗体的进一步数据 网页链接 $ORIC制药(ORIC)$ 拥有同靶点pipeline查看全文
残酷的行情2021-03-25 22:25
智通财经APP获悉,ORIC制药公司(ORIC.US)宣布与辉瑞(PFE.US)就多发性骨髓瘤候选药物进行合作,并获得辉瑞的股权投资。截至发稿,ORIC制药(ORIC.US)股价于盘后交易中飙升64.67%报4.94美元。 ORIC-533是一种CD73抑制剂,目前处于1期。两家... 网页链接
$ORIC Pharmaceuticals(ORIC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-053582 Act: 34 Size: 5 MB 网页链接
$ORIC Pharmaceuticals(ORIC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-053551 Act: 34 Size: 381 KB 网页链接
$ORIC Pharmaceuticals(ORIC)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-110119 Act: 34 Size: 3 MB 网页链接
$ORIC Pharmaceuticals(ORIC)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-110069 Act: 34 Size: 509 KB 网页链接
$ORIC Pharmaceuticals(ORIC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-110091 Act: 34 Size: 425 KB 网页链接
$ORIC Pharmaceuticals(ORIC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-082131 Act: 33 Size: 98 KB 网页链接
$ORIC Pharmaceuticals(ORIC)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-082077 Act: 34 Size: 267 KB 网页链接
$ORIC制药(ORIC)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-24-064987 Act: 33 Size: 868 KB 网页链接
$ORIC制药(ORIC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-029298 Act: 34 Size: 13 MB 网页链接
$ORIC制药(ORIC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-029239 Act: 34 Size: 414 KB 网页链接